Cite Filings / EWTX / 0001558370-25-010655
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Edgewise Therapeutics, Inc. · Filed 2025-08-07 · Acc 0001558370-25-010655

Documents 1

  • 10-Q Quarterly Report , ewtx-20250630x10q.htm

Around this filing

  • 2025-11-06 10-Q Quarterly Report
  • 2025-08-14 4 Chief Scientific Officer sold 1,907 shares at $13.39 ($25,539)
  • 2025-08-14 4 President and CEO sold 7,972 shares at $13.39 ($106,764)
  • 2025-08-14 4 CMO sold 2,862 shares at $13.39 ($38,329)
  • 2025-08-07 10-Q Quarterly Report
  • 2025-08-07 8-K Results of operations
  • 2025-05-08 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading ewtx-20250630x10q.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…